Skip to Main Content

Paper Details

Estimated Annual Spending on Lecanemab and Its Ancillary Costs in the US Medicare Program.
JAMA Intern Med
5
2023
Lecanemab, lecanemab
Author NameAffiliation
Catherine A SarkisianDivision of General Internal Medicine and Health Services Research, David Geffen School of Medicine at University of California los angeles
Catherine A SarkisianVA Greater Los Angeles Healthcare System Geriatrics Research & Clinical Center (GRECC)
Catherine A SarkisianDivision of General Internal Medicine and Health Services Research, David Geffen School of Medicine at University of California los angeles
Catherine A SarkisianVA Greater Los Angeles Healthcare System Geriatrics Research & Clinical Center (GRECC)
Bruce E LandonHarvard Medical School and the Division of General Medicine, Beth Israel Deaconess Medical Center
John N MafiDivision of General Internal Medicine and Health Services Research, David Geffen School of Medicine at University of California los angeles
John N MafiRAND Corporation
  • 1 - 7

Datasets